Cytogenetic confirmation of a gastrointestinal stromal tumor and Ewing sarcoma/primitive neuroectodermal tumor in a single patient

被引:12
作者
Kondo, S
Yamaguchi, U
Sakurai, S
Ikezawa, Y
Chuman, H
Tateishi, U
Furuta, K
Hasegawa, T
机构
[1] Sapporo Med Univ, Sch Med, Dept Clin Pathol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
[3] Natl Canc Ctr, Div Orthoped Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Div Clin Lab, Tokyo, Japan
[5] Natl Canc Ctr, Div Diagnost Radiol, Tokyo, Japan
[6] Gunma Univ, Grad Sch Med, Dept Pathol, Maebashi, Gumma 371, Japan
[7] Mito Saiseikai Hosp, Div Orthoped Surg, Mito, Ibaraki, Japan
关键词
gastrointestinal stromal tumor (GIST); Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET); KIT/c-kit; platelet-derived growth factor alpha (PDGFRA);
D O I
10.1093/jjco/hyi197
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a rare case in which two tumor entities, a gastrointestinal stromal tumor (GIST) and Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET), with distinct cytogenetic features occurred in a single patient. The patient was a 72-year-old woman. The first tumor was a submucosal gastric tumor and was diagnosed as a low-risk group GIST based on morphological characteristics and the results of an immunohistochemical analysis for c-kit and CD34. Further cytogenetic analysis revealed that this tumor had a point mutation (D842V substitution) in exon 18 of the platelet-derived growth factor receptor alpha gene. The second tumor was found more than 4 years after the appearance of the first tumor. ES/PNET was highly suspected both morphologically and immunohistochemically, and the diagnosis was confirmed by the detection of an EWS rearrangement using a fluorescence in situ hybridization technique. Although the cytogenetic correlations of these two tumors are unclear, accurate histologic recognition is of clinical importance because the treatments for these two tumors differ.
引用
收藏
页码:753 / 756
页数:4
相关论文
共 18 条
[1]   Biology of EWS/ETS fusions in Ewing's family tumors [J].
Arvand, A ;
Denny, CT .
ONCOGENE, 2001, 20 (40) :5747-5754
[2]   Biology of gastrointestinal stromal tumors [J].
Corless, CL ;
Fletcher, JA ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3813-3825
[3]  
FALK S, 1967, SURG GYNECOL OBSTETR, V124, P319
[4]   Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone [J].
Grier, HE ;
Krailo, MD ;
Tarbell, NJ ;
Link, MP ;
Fryer, CJH ;
Pritchard, DJ ;
Gebhardt, MC ;
Dickman, PS ;
Perlman, EJ ;
Meyers, PA ;
Donaldson, SS ;
Moore, S ;
Rausen, AR ;
Vietti, TJ ;
Miser, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08) :694-701
[5]   PDGFRA activating mutations in gastrointestinal stromal tumors [J].
Heinrich, MC ;
Corless, CL ;
Duensing, A ;
McGreevey, L ;
Chen, CJ ;
Joseph, N ;
Singer, S ;
Griffith, DJ ;
Haley, A ;
Town, A ;
Demetri, GD ;
Fletcher, CDM ;
Fletcher, JA .
SCIENCE, 2003, 299 (5607) :708-710
[6]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[7]   Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J].
Joensuu, H ;
Roberts, PJ ;
Sarlomo-Rikala, M ;
Andersson, LC ;
Tervahartiala, P ;
Tuveson, D ;
Silberman, SL ;
Capdeville, R ;
Dimitrijevic, S ;
Druker, B ;
Demetri, GD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1052-1056
[8]   Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996 [J].
Kaneko, S ;
Yamaguchi, N .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (02) :96-105
[9]   Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas [J].
Lasota, J ;
Jasinski, M ;
Sarlomo-Rikala, M ;
Miettinen, M .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :53-60
[10]  
Merimsky O, 2001, CANCER, V91, P1363, DOI 10.1002/1097-0142(20010401)91:7<1363::AID-CNCR1140>3.0.CO